Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Houssin

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Anti-Cancer Drug Design|May 21, 1999
Synthesis and antiproliferative properties of 4-aminoquinazoline derivatives as inhibitors of EGF receptor-associated tyrosine kinase activityE Bouey-Bencteux, C Loison, N Pommery, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2001
N-Aminoindoline derivatives as inhibitors of 5-lipoxygenaseC Audouin, N Mestdagh, M A Lassoie, et al.
Anti-Cancer Drug Design|April 1, 1987
Design of two metal-chelating, DNA-binding models: molecular combinations of bleomycin and amsacrine anti-tumour drugsC Bailly, J L Bernier, R Houssin, et al.
Cancer Biochemistry Biophysics|September 1, 1984
Subcellular distribution of spin-labeled bithiazoles and bleomycin in living KB cells: an ESR studyJ P Henichart, J L Bernier, P Lemay, et al.
Annales Pharmaceutiques Francaises|November 1, 1977
[1-(2-hydroxyethyl)-1,2,4-triazole esters]B Lablanche, J P Hénichart, R Houssin, et al.
Biochemical and Biophysical Research Communications|April 29, 1988
DNA-binding and DNA-cleaving properties of a synthetic model AGAGLU related to the antitumour drugs AMSA and bleomycinC Bailly, A Kenani, N Helbecque, et al.
The Biochemical Journal|April 15, 1996
One-electron oxidation of ergothioneine and analogues investigated by pulse radiolysis: redox reaction involving ergothioneine and vitamin CK D Asmus, R V Bensasson, J L Bernier, et al.
Anti-Cancer Drug Design|March 1, 1995
Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNAB Plouvier, R Houssin, N Helbecque, et al.
Biochemical and Biophysical Research Communications|February 15, 1985
Copper(II)- and iron(II)-complexes of methyl 2-(2-aminoethyl)-aminomethyl-pyridine-6-carboxyl-histidinate (AMPHIS), a peptide mimicking the metal-chelating moiety of bleomycin. An ESR investigationJ P Hénichart, J L Bernier, R Houssin, et al.
Journal of Medicinal Chemistry|July 14, 2000
Synthesis and pharmacological evaluation of new pyrazolidine-3, 5-diones as AT(1) angiotensin II receptor antagonistsB Le Bourdonnec, E Meulon, S Yous, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Anti-Cancer Drug Design|May 21, 1999
Synthesis and antiproliferative properties of 4-aminoquinazoline derivatives as inhibitors of EGF receptor-associated tyrosine kinase activityE Bouey-Bencteux, C Loison, N Pommery, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2001
N-Aminoindoline derivatives as inhibitors of 5-lipoxygenaseC Audouin, N Mestdagh, M A Lassoie, et al.
Anti-Cancer Drug Design|April 1, 1987
Design of two metal-chelating, DNA-binding models: molecular combinations of bleomycin and amsacrine anti-tumour drugsC Bailly, J L Bernier, R Houssin, et al.
Cancer Biochemistry Biophysics|September 1, 1984
Subcellular distribution of spin-labeled bithiazoles and bleomycin in living KB cells: an ESR studyJ P Henichart, J L Bernier, P Lemay, et al.
Annales Pharmaceutiques Francaises|November 1, 1977
[1-(2-hydroxyethyl)-1,2,4-triazole esters]B Lablanche, J P Hénichart, R Houssin, et al.
Biochemical and Biophysical Research Communications|April 29, 1988
DNA-binding and DNA-cleaving properties of a synthetic model AGAGLU related to the antitumour drugs AMSA and bleomycinC Bailly, A Kenani, N Helbecque, et al.
The Biochemical Journal|April 15, 1996
One-electron oxidation of ergothioneine and analogues investigated by pulse radiolysis: redox reaction involving ergothioneine and vitamin CK D Asmus, R V Bensasson, J L Bernier, et al.
Anti-Cancer Drug Design|March 1, 1995
Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNAB Plouvier, R Houssin, N Helbecque, et al.
Biochemical and Biophysical Research Communications|February 15, 1985
Copper(II)- and iron(II)-complexes of methyl 2-(2-aminoethyl)-aminomethyl-pyridine-6-carboxyl-histidinate (AMPHIS), a peptide mimicking the metal-chelating moiety of bleomycin. An ESR investigationJ P Hénichart, J L Bernier, R Houssin, et al.
Journal of Medicinal Chemistry|July 14, 2000
Synthesis and pharmacological evaluation of new pyrazolidine-3, 5-diones as AT(1) angiotensin II receptor antagonistsB Le Bourdonnec, E Meulon, S Yous, et al.
Pageof 4